203 related articles for article (PubMed ID: 22189356)
21. Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
Palmer ND; Ng MC; Hicks PJ; Mudgal P; Langefeld CD; Freedman BI; Bowden DW
PLoS One; 2014; 9(2):e88273. PubMed ID: 24551085
[TBL] [Abstract][Full Text] [Related]
22. In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress.
Anderson BR; Howell DN; Soldano K; Garrett ME; Katsanis N; Telen MJ; Davis EE; Ashley-Koch AE
PLoS Genet; 2015 Jul; 11(7):e1005349. PubMed ID: 26147622
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy.
Larsen CP; Beggs ML; Saeed M; Walker PD
J Am Soc Nephrol; 2013 Apr; 24(5):722-5. PubMed ID: 23520206
[TBL] [Abstract][Full Text] [Related]
24. Copy Number Variation at the APOL1 Locus.
Ruchi R; Genovese G; Lee J; Charoonratana VT; Bernhardy AJ; Alper SL; Kopp JB; Thadhani R; Friedman DJ; Pollak MR
PLoS One; 2015; 10(5):e0125410. PubMed ID: 25933006
[TBL] [Abstract][Full Text] [Related]
25. MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
Kopp JB; Winkler CA; Nelson GW
Semin Nephrol; 2010 Jul; 30(4):409-17. PubMed ID: 20807613
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans.
Cooke JN; Bostrom MA; Hicks PJ; Ng MC; Hellwege JN; Comeau ME; Divers J; Langefeld CD; Freedman BI; Bowden DW
Nephrol Dial Transplant; 2012 Apr; 27(4):1505-11. PubMed ID: 21968013
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
[TBL] [Abstract][Full Text] [Related]
28. The spectrum of MYH9-associated nephropathy.
Bostrom MA; Freedman BI
Clin J Am Soc Nephrol; 2010 Jun; 5(6):1107-13. PubMed ID: 20299374
[TBL] [Abstract][Full Text] [Related]
29. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
Freedman BI; Hicks PJ; Bostrom MA; Cunningham ME; Liu Y; Divers J; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Kidney Int; 2009 Apr; 75(7):736-45. PubMed ID: 19177153
[TBL] [Abstract][Full Text] [Related]
30. The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.
Rosset S; Tzur S; Behar DM; Wasser WG; Skorecki K
Nat Rev Nephrol; 2011 Jun; 7(6):313-26. PubMed ID: 21537348
[TBL] [Abstract][Full Text] [Related]
31. The MYH9/APOL1 region and chronic kidney disease in European-Americans.
O'Seaghdha CM; Parekh RS; Hwang SJ; Li M; Köttgen A; Coresh J; Yang Q; Fox CS; Kao WH
Hum Mol Genet; 2011 Jun; 20(12):2450-6. PubMed ID: 21429915
[TBL] [Abstract][Full Text] [Related]
32. ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.
Blazer AD; Clancy RM
Curr Rheumatol Rep; 2017 Mar; 19(3):13. PubMed ID: 28265848
[TBL] [Abstract][Full Text] [Related]
33. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
Behar DM; Rosset S; Tzur S; Selig S; Yudkovsky G; Bercovici S; Kopp JB; Winkler CA; Nelson GW; Wasser WG; Skorecki K
Hum Mol Genet; 2010 May; 19(9):1816-27. PubMed ID: 20144966
[TBL] [Abstract][Full Text] [Related]
34. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
Freedman BI; Hicks PJ; Bostrom MA; Comeau ME; Divers J; Bleyer AJ; Kopp JB; Winkler CA; Nelson GW; Langefeld CD; Bowden DW
Nephrol Dial Transplant; 2009 Nov; 24(11):3366-71. PubMed ID: 19567477
[TBL] [Abstract][Full Text] [Related]
35. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
[TBL] [Abstract][Full Text] [Related]
36. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
37. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
38. Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.
Johnstone DB; Zhang J; George B; Léon C; Gachet C; Wong H; Parekh R; Holzman LB
Mol Cell Biol; 2011 May; 31(10):2162-70. PubMed ID: 21402784
[TBL] [Abstract][Full Text] [Related]
39. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
Kopp JB; Smith MW; Nelson GW; Johnson RC; Freedman BI; Bowden DW; Oleksyk T; McKenzie LM; Kajiyama H; Ahuja TS; Berns JS; Briggs W; Cho ME; Dart RA; Kimmel PL; Korbet SM; Michel DM; Mokrzycki MH; Schelling JR; Simon E; Trachtman H; Vlahov D; Winkler CA
Nat Genet; 2008 Oct; 40(10):1175-84. PubMed ID: 18794856
[TBL] [Abstract][Full Text] [Related]
40. Association between
Zhao H; Ma L; Yan M; Wang Y; Zhao T; Zhang H; Liu P; Liu Y; Li P
J Diabetes Res; 2018; 2018():5068578. PubMed ID: 29862302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]